We are Sorry, This Page doesn't Exist
Why Precision BioSciences Stock Is Trading Higher Today
Precision BioSciences (NASDAQ: DTIL) shares are trading higher after the company reported its ARCUS platform showed a promising gene editing approach for transthyretin amyloidosis. read more.....»»
Akoya Biosciences started t buy with $25 stock price target at Canaccord Genuity
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Selecta Biosciences Stock Is Estimated To Be Possible Value Trap
Related Stocks: SELB,.....»»
Selecta Biosciences Stock Is Trading Lower After Gaining Total Rights To MMA Program From AskBio
read more.....»»
Arcus Biosciences Stock Is Believed To Be Possible Value Trap
Related Stocks: RCUS,.....»»
Arcadia Biosciences Stock Appears To Be Possible Value Trap
Related Stocks: RKDA,.....»»
IGM Biosciences price target raised to $119 from $86 at Truist Securities, stock rated buy
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Evofem Biosciences stock tumbles toward a record low, after public stock offering prices at 25% discount
Shares of Evofem Biosciences Inc. tumbled 24.9% toward a record low in premarket trading Thursday, after the biopharmaceutical company focused on women's sexual and reproductive health announced .....»»
Aptose Biosciences Stock Trades Higher After Q4 Earnings: Technical Levels To Watch
Aptose Biosciences Inc. (NASDAQ: APTO) shares traded higher after the company’s release of fourth-quarter results Tuesday. read more.....»»
What"s Happening With APTO Stock And SNES Stock Today?
Aptose Biosciences Inc (NASDAQ: APTO) shares are trading higher after the company reported fourth-quarter earnings results. Oppenheimer analyst Matthew Biegler also maintains Aptose with an Outperform and raises the price target from $8 to $9. read more.....»»
Why Benitec Biopharma (BNTC) Stock Is Skyrocketing Today
The shares of Benitec Biopharma Inc (NASDAQ: BNTC) are trading 92.5% higher at $6.14 in the early pre-market session on Tuesday. What Happened: Benitec shares had closed at $3.19 on Monday. read more.....»»
Anixa Biosciences announces $10M bought deal offering of common stock
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Selecta Biosciences Chief Medical Officer buys 20K shares of common stock
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences announces $85M common stock offering
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences files to sell 24.3M shares of common stock for holders
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Artelo Biosciences stock price target raised to $5 from $3 at Maxim Group
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Pacific Biosciences stock rockets ahead of earnings, after Softbank makes $900 million investment
Shares of Pacific Biosciences of California Inc. shot up 22.3% toward a recor.....»»
Kaleido Biosciences announces $50M common stock offering
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Arcadia Biosciences files to sell 12.21M shares of common stock for holders
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead buys more Arcus Biosciences stock, at a price above the record close
Arcus Biosciences Inc. disclosed Monday that Gilead Sciences Inc. boosted its stake in the oncology-focused biopharmaceutical company, through the purchase of $220.35 million worth of stock. Arcus shares were still inactive in pr.....»»